James H. Sabry, Director at CYTOKINETICS INC (CYTK), sold 134,200 shares at $3.34 ($447K) on 2009-11-13, disclosed to the SEC on 2009-11-17.
Open-market sale of $447k CYTK by Director. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $0.00 | 2,000 | $0 | 0.0% |
| 2 | $3.34 | 9,060 | $30K | 6.8% |
| 3 | $3.34 | 10,440 | $35K | 7.8% |
| 4 | $3.35 | 23,500 | $79K | 17.6% |
| 5 | $3.35 | 19,500 | $65K | 14.6% |
| 6 | $3.36 | 1,700 |
| $6K |
| 1.3% |
| 7 | $3.36 | 1,504 | $5K | 1.1% |
| 8 | $3.37 | 496 | $2K | 0.4% |
| 9 | $3.38 | 100 | $338 | 0.1% |
| 10 | $3.39 | 541 | $2K | 0.4% |
| 11 | $3.40 | 6,255 | $21K | 4.8% |
| 12 | $3.41 | 8,498 | $29K | 6.5% |
| 13 | $3.42 | 31,306 | $107K | 23.9% |
| 14 | $3.42 | 400 | $1K | 0.3% |
| 15 | $3.43 | 8,594 | $29K | 6.6% |
| 16 | $3.44 | 5,066 | $17K | 3.9% |
| 17 | $3.45 | 5,240 | $18K | 4.0% |
| Total | $3.33 avg | 134,200 | $447K | 100% |
| Filing → |
| CYTK | SELL | 2010-05-14 | $30K | — | Filing → |
| CYTK | SELL | 2010-04-28 | $32K | — | Filing → |
| CYTK | SELL | 2010-04-01 | $32K | — | Filing → |